Purus Labs® Secures Deal to Introduce Patent-Pending TeaCrine™ to the World With New Thermogenic TheaTrim™

Share Article

Purus Labs® Purus Labs® introduces patent-pending TeaCrine™ to the world with new thermogenic TheaTrim™ to be released before the end of the year.

News Image
For six years, Purus Labs® has provided the maximal, science-based formulas to its loyal client base.

TeaCrine™ is the world’s first IP-protected, branded, and “natureidentical” source of theacrine. This patent-pending purine alkaloid is found naturally in the leaves of the legendary Chinese Camellia assamica var. Kucha tea and in the fruit of the Brazilian Cupuaçu plant. Purus Labs® will be featuring this formula in their new product TheaTrim™, set to launch later this year.

“The market potential for TeaCrine™ is significant and we are excited to extend our portfolio with this product,” said Matt Titlow, CEO of Compound Solutions, Inc®. “The addition of TeaCrine™ to our extensive distribution network and product portfolio is a great fit and we are thrilled to offer it to the our customers and the broader market.”

The thermogenic category has been stagnant and lacking ingenuity for quite some time. Purus Labs®, adhering to their commitment of producing scientifically validated formulas, set out to develop and introduce a truly effective thermogenic that would address the weight loss concerns of some 51% of Americans (Gallup®). Founder and CEO Brandon Smith exclaimed, “We are extremely excited about our role in introducing TeaCrine™ to the world. We have already conducted studies in humans with three different formulas to determine which had the greatest effect on energy and weight loss. Purus Labs’ TheaTrim™ will be available before the end of the year.”

The ingredient is being heralded as “beyond caffeine” and “clean energy that moves you and does not relent” by early users and has garnered notable excitement in the industry.

Dr. Tim Ziegenfuss, who oversaw the human TeaCrine™ studies at the Center for Applied Health Sciences notes, “Multiple studies with animal and human models have reported additional benefits beyond the typical neurochemistry of caffeine, such as improved alertness and neural drive, analgesia (reduced sensation of discomfort), liver health, and diminished adaptation or sensitization phenomena. Hence, this initial interrogation is just the tip of the iceberg of potential functional benefits related to TeaCrine™.”

The first-in-human, seminal research findings were presented at the International Society of Sports Nutrition (ISSN) Conference in Clearwater, FL on June 21st, 2014. While TeaCrine™ generated significant “buzz” at ISSN, it is just the beginning. Compound Solutions is mounting a robust clinical research campaign for TeaCrine™ supplementation.

Compound Solutions specializes in supplying new, patented ingredients and amino acids to the fast-growing sports nutrition and nutritional supplement industries. Matt Titlow, CEO of Compound Solutions, said, “Our team is proud and excited to be a part of Purus Lab®’s new product launch. For six years, Purus Labs® has provided the maximal, science-based formulas to its loyal client base.”

About Purus Labs®, Inc.:
Purus Labs® is a global sports nutrition company providing unique scientifically researched products for the dietary supplement industry. Since 2008, Purus Labs® has been at the forefront of innovation in the marketplace, being one of the first companies to offer products with full label disclosure and no proprietary blends. Focusing on quality control, Purus Labs® opened their own manufacturing facility, complete with an analytical lab and principle chemist in 2012.

For more information, visit puruslabs.net or contact Meaghan Oven at (214)221-1813.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Meaghan Oven
Purus Labs
+1 214-221-4911
Email >
Visit website